The Clinical Application of Clostridium Butyricum Miyairisan for Motor and Non-motor Symptoms in Parkinson's Disease

ConditionsClostridium Butyricum Miyairi Parkinson Disease

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age20-90

SponsorKaohsiung Medical University Chung-Ho Memorial Hospital

About this trial

This is an open-label, single-center, non-randomized study to assess the efficacy of Clostridium Butyricum Miyairi on the motor and non-motor symptoms of Parkinson's disease

Eligibility criteria

Qualifiers

Male or female over 20 years old, diagnosed with Parkinson's disease.

Disqualifiers

People with Parkinson's disease Dementia, or Lactose Intolerance

Trial design

Treatments tested in this trial

Miyarisan-BM (Clostridium Butyricum Miyairi)

Treatment groups

400 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Kaohsiung Medical University Chung-Ho Memorial Hospital

Lead sponsor

Source ClinicalTrials.gov